Suspended

GBR 12909 Study in Cocaine Experienced African American Volunteers

What is being tested

Data Collection

Who is being recruted

Mental Disorders+1

+ Substance-Related Disorders

+ Cocaine-Related Disorders

From 18 to 45 Years

+5 Eligibility Criteria

See all eligibility criteria

How is the trial designed

Treatment Study

Phase 1

Interventional

Study Start: April 2004

See protocol details

Summary

Principal SponsorNational Institute on Drug Abuse (NIDA)

Last updated: January 27, 2026

Sourced from a government-validated database.Claim as a partner

Study start date: April 1, 2004

Actual date on which the first participant was enrolled.

Double-blind, placebo-controlled, safety and pharmacology study with 75 mg dosage of GBR 12909 in cocaine experienced African American Volunteers. Particular interest is being given to the hematological safety data.

Official TitleGBR 12909 Study in Cocaine Experienced African American Volunteers

NCT00089687

Principal SponsorNational Institute on Drug Abuse (NIDA)

Last updated: January 27, 2026

Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Design Details

10 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Treatment Study

These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.

Conditions

Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 18 to 45 Years

Range of ages for which participants are eligible to join.

Healthy volunteers allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Mental DisordersSubstance-Related DisordersCocaine-Related DisordersChemically-Induced Disorders

Criteria

4 inclusion criteria required to participate

Must be within 20% of ideal body weight and must weigh at least 45 kg.

Must understand the study procedures and provide written informed consent.

Must meet DSM-4 criteria for abuse or dependence on cocaine.

Must be non-treatment seeking at the time of the study.

1 exclusion criteria prevent from participating

Please contact the study site for more information.

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.

Study Objectives

Primary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Suspended

Uniformed Services University of Health Science

Bethesda, United StatesOpen Uniformed Services University of Health Science in Google Maps

SuspendedOne Study Center